Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor

Vaccines that incorporate peptide mimics of tumor antigens, or mimotope vaccines, are commonly used in cancer immunotherapy and function by eliciting increased numbers of T cells that cross-react with the native tumor antigen. Unfortunately, they often elicit T cells that do not cross-react with or...

Descripción completa

Detalles Bibliográficos
Autores principales: Buhrman, Jonathan D., Jordan, Kimberly R., Munson, Daniel J., Moore, Brandon L., Kappler, John W., Slansky, Jill E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2013
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829168/
https://www.ncbi.nlm.nih.gov/pubmed/24106273
http://dx.doi.org/10.1074/jbc.M113.509554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829168/
https://www.ncbi.nlm.nih.gov/pubmed/24106273
http://dx.doi.org/10.1074/jbc.M113.509554

Ejemplares similares